摘要
目的
观察藿香正气散治疗感冒挟湿的临床疗效和安全性,以期为临床应用提供安全性和药效学依据。
方法
研究对象为符合感冒挟湿的辨证标准,同时符合西医普通感冒诊断标准的患者。随机分为两组,治疗组服用藿香正气散,对照组采用利巴韦林注射联合复方氨酚烷胺胶囊口服,以临床综合疗效、中医症状评分为观察指标,评价藿香正气散的有效性和安全性。统计方法：分类资料用χ2检验,等级资料用两样本比较Wilcoxon秩和检验(校正),两样本均数比较用t检验或Wilcoxon秩和检验,自身前后比较用配对t检验或Wilcoxon配对秩和检验。
结果
本次研究共有合格受试者90例,治疗组45例,男23例,女22例,年龄18-50岁,平均年龄37.5±9.7岁；对照组45例,男20例,女25例,年龄19-50岁,平均年龄39.8±7.9岁。均为门诊病人。
治疗前可比性检测表明,两组治疗前年龄、病程、病情程度等各项指标比较,差异均无显著性意义。提示影响两组预后的主要因素具有均衡性。
治疗组治疗后痊愈率为55.6%,显效率为17.8%,有效率为15.6%；而对照组治疗后痊愈率为13.3%,显效率为13.3%,有效率为44.4%。经比较,两组总疗效差异有统计学意义(P<0.05)。
治疗3天后,两组在改善感冒症状(恶寒、发热、鼻塞、流涕、自汗、头痛、咳嗽吐痰、脘闷恶心、纳差、体倦乏力、肢体酸痛、便溏、恶风)程度上,差异有统计学意义(P<0.05)。
两组治疗3天后,恶寒、发热、鼻塞、恶风、流涕、自汗、头痛、咳嗽吐痰、肠鸣腹泻、脘闷恶心、纳差、体倦乏力、肢体酸痛、便溏症状消失率两组比较差异有统计学差异(P<0.05)。
两组治疗前后血常规、血糖、肝功能、肾功能经检测差异无统计学意义(P>0.05),可认为两组药均安全可靠。
结论
总疗效比较,治疗组的总有效率为88.9%,对照组的总有效率为71.1%,经比较,差异有统计学意义(P<0.05),可认为治疗组疗效优于对照组。
治疗组在恶寒、发热、鼻塞、流涕、自汗、头痛、咳嗽吐痰、脘闷恶心、纳差、体倦乏力、肢体酸痛、便溏、恶风症状的改善作用与对照组比较,差异有显著性意义(P<0.05)。提示治疗组在改善上述症状作用上较对照组有优势。
藿香正气散具有解表化湿,理气和中的作用。对感冒挟湿有较好的疗效,并且临床检测本方安全可靠。
Objective
To observe the clinical curative effect and safety about the curatio of Agastachis Powder for Restoring Healthy Energy on diseases caused by exogenous pathogenic factor with moist type cold in order to offer its safety and pharmacodynamics basis on clinical application.
Methods
The research objects were the ones which fit the standard of diseases caused by exogenous pathogenic factor with moist type cold, match the standard of medical common code as well. Randomly divided them into two groups, the treatment group was used by Agastachis Powder for Restoring Healthy Energy, the control group was deployed ribovirin injection associate complex prescription AM alcohol phenyl-ane amine caps for oral use. To estimate the availability and safety of Agastachis Powder for Restoring Healthy Energy by standard on clinical synthetic curative effect and TCMsymptom score. Statistical method:classify data tested byχ2 test, ranked data was used the comparison between two samples which were Wilcoxon rank sum test(corrected). The comparison between two samples'mean tested by using Wilcoxon rank sum test.The self AP:PA comparison used matched-pairs test t or Wilcoxon rank sum test.
Results
There were 90 cases of qualified subjects,45cases were treatment group, (23cases of man,22cases of woman) the age from 18 to 50, the average age is 37.5±9.7,45cases were control group(20cases of men,25cases of women) the age from 19 to 50years old, the average age was 39.8±7.9years. All subjects were medical outpatient.
Prior treatment comparability test indicated that there weren't significant senses on the comparison about age, course of disease, pathogenetic conditionDEG and every index which cued that the major factor on effecting prognostic result possessed equilibration. The treatment group after treatment was 55.6%, the excellence rate was 13.3%, the effective power was 15.6%. The healing rate of control group is 13.3%, the excellence rate was 13.3%, the effective power was 44.4%. After comparison, there was statistical significance on the differences between two groups on curative effects(P<0.05).
After 3-day treatment, there was statistical significance on improving cold symptom (nephrasthenia asthma, calor febrilis, nasal obstruction, nasal discharge, spontaneous perspiration, angina capitis, begma and spit, gastric cavity tightly closed and sicchasia, nauseated, tired and debilitation, limbs aching pain, loose stool, aversion to wind)differences between two groups(P<0.05).
After 3-day treatment, there was statistical significance on different disappearance rate between two groups on nephrasthenia asthma, calor febrilis, nasal obstruction, nasal discharge, spontaneous perspiration, angina capitis, begma and spit, gastric cavity tightly closed and sicchasia, nauseated, tired and debilitation, limbs aching pain, loose stool, aversion to wind(P<0.05).
There was not statistically significant on blood convention、blood glucose、liver function and renal function after treatment(P>0.05). It was considered that two groups of medicine were safe. Conclusion
According to total curative effect comparison, the total effective rate of treatment group was 88.9%, the total effective rate of control group was 71.1%. There was statistical significance so that we can conclude that the curative effect of healing group was better than the control group (P<0.05).
There was significant difference between two groups of improving effect on curing nephrasthenia asthma, calor febrilis, nasal obstruction, nasal discharge, spontaneous perspiration, angina capitis, begma and spit, gastric cavity tightly closed and sicchasia, bad nano, tired and debilitation, limbs aching pain, loose stool, aversion to wind(P<0.05). The result cued that the curative effect on above-mentioned symptom of the healing group was better than control group.
Agastachis Powder for Restoring Healthy Energy not only could diaphoresis relieving superficies and dissipating dampness but also principle the breath. It done well in diseases caused by exogenous pathogenic factor with moist type cold treatment and the clinical detection was safe and reliability.
引文
[1]中国中医研究院.正柴胡饮冲剂治疗普通感冒[J].中医杂志,1985,12(13)：38.
[2]杜氏中医治疗风寒感冒[J].中医杂志,1985,10(39)：78.
[3]宋华妮.葛根汤合剂治疗感冒的随机双盲对照研究[J].临床荟萃,2005,3(20),96-98.
[4]胡亚光.严继林教授对昆明地区感冒的治疗经验[J].云南中医学院学报,2001,9(24)：78.
[5]吴向红.加味真武汤治疗感冒33例[J].四川中医,1993,6(7)：69.
[6]冯蓉.穿琥宁注射液治疗普通感冒25例临床观察[J].成都医药,1997,23(2)：46-47.
[7]赖跃进.羌蒲汤治疗风热感冒三百例[J].天津中医药,2005,6(22)：74-76.
[8]常静,李延谦.金莲清胶囊治疗急性上呼吸道感染的随机双盲对照试验[J].中国循证医学杂志,2005,5(8)：121-123.
[9]张轶鹏.藿香正气汤治疗胃肠型感冒验案浅析[J].实用中医杂志,2005,19(4)：143.
[10]显感汤治疗暑湿感冒的临床观察[J].江西中医药,1995,26(47)：37.
[11]李洪功.麻黄附子细辛汤加味治疗肾阳虚感10例分析[J].社区中医药,1996,10(20)：11.
[12]张杰.清毒退热散治疗流感临床观察[J].河北中医,2005,4(27)：4.
[13]张俊庚.清瘟解毒汤治疗时行感冒[J].山东中医药,2002,9(21)：56-57.
[14]高又新.银葛双解冲剂抗流感A3型的药效试验研究[J].中国中医科技,1995,2(4)：98.
[15]黄燕.任继学教授治疗暑温夹湿验案[J].中华现代中医杂志,2004,7(24)：78.
[16]孟洁.流感的季节治疗临床观察[J].中华现代中医杂志,2004,3(22)：88.
[17]叶寿山.莪术油软胶囊抗病毒作用研究[J].中药药理与临床,2005,21(3)：121-122.
[18]徐刚.抗湿热片解表化湿作用的研究[J].中国中医药科技,1999,6(4)：65.
[19]杜淑云.升降散加减治疗时行感冒56例[J].北京中医,1999,3(9)：37.
[20]张俊庚.时行感冒治疗心得[J].中国中医急证,2002,8(11)：40.
[21]中医专家提出中医防治人禽流感思路[N].中国中医药报,2005-10-24(3).
[22]洪炳根.中医防治流感非典初探[J].福建中医药,2005,8(36)48.
[23]彭述均.学习著名中医学家治疗外感热病的体会[J].江西中医,2004,11(36)：88.
[24]郭莫新.感冒治疗的误区[J].中国卫生保健,2005,19(8)：43.
[25]郑洪.呼吸道病毒感染的病原体变异及流行趋势[J].临床荟萃,2005,20(10)：134-135.
[26]李军.鼻病毒的现状研究[J].中华儿科杂志,2005,43(1)：64.
[27]樊淑源.中药在抗病毒领域的临床运用[J].现代中西医结合杂志,2005,14(16)：74.
[28]李志强.感冒病情分析与用药体会[J].职业与健康,2005,21(10)：80.
[29]苗青原.抗感冒药应用情况分析[J].齐鲁药事,2005,24(8)：35.
[30]感冒用药(西药篇)[J].医药世界,2004,6：55.
[31]张忠华.感冒方药的抗病毒实验研究[J].实用中医内科杂志,2005,19(4)：57-59.
[32]清华大学冠状病毒研究获新突破[J].健康大视野,2005,10(3)：47,33.
[33]林智辉,赵聚山.《时病论》治法探究[J].南京中医药大学学报,2004,11(20)：6.
[34]高桂新.感冒双解合剂抗流感病毒感染小鼠免疫损伤的机制研究[D].北京中医药大学,2004.
[35]陶洪流.“羌荆石甘汤”治疗儿童流行性感冒发热48例[J].江苏中医,1999,(11).
[36]任继学.时行感冒[J].中国中医药现代远程教育,2004,(05).
[37]王东.时行感冒的中医药治疗[J].吉林中医药,2003,(06).
[38]周平安,焦扬.暖冬流感表寒里热[N].健康报,2007,(04).
[39]焦树德.中医药防治流感[J].中国中医急症,1999,8(1)：5.
[40]李丽华.时行感冒治验心得[J].江西中医药,2006,(02).
[41]海音.流行性感冒中医如何辨治[N].上海中医药报,2006.
[42]李文旭.流行性感冒的中医学认识与临床[J].中医研究,1996,(02).
[43]张俊庚,张磊,朱爱青.时行感冒治疗心得[J].中国中医急症,2002,(04).
[44]金毅,廖雄英.甘露消毒丹临床引伸应用近况[J].时珍国医国药,1996,(03).
[45]冯颖娥,何晓凤.柴葛解肌汤合麻杏石甘汤治疗时行感冒102例[J].陕西中医,2003,(03).
[46]于香军,姜金英.正柴胡饮治疗流行性感冒108例[J].实用中医内科杂志,1997,(01).
[47]张兆渠,崔向金.柴银汤治疗流行性感冒200例[J].实用中医药杂志,2000,(09).
[48]孟杰,程红.中医药治疗时行感冒78例[J].河南中医,2002,(05).
[49]杨少锋,陈宝田,罗仁.外感解热灵治疗外感发热77例疗效分析[J].新中医,1994,(01).
[50]王亚敏,宁淑珍.三石汤加减治疗夏季重症流感[J].中国中医急症,1997,(02).
[51]姜良铎,张晓梅,周平安,等.从“天人合一”理论探讨1998年冬季北京地区流感特点[J].中国医药学报,2000,(01).
[52]邓淑莉.消毒凉膈散加减治疗流感157例[J].山东中医杂志,1991,(02).
[53]刘剑,白时琴.银黄石防汤治疗流感高热28例[J].四川中医,2001,(08).
[54]路志正.流感防治方药[J].中国中医急症,1999,(01).
[55]杨东红.小柴胡汤治疗病毒性上感高热35例临床观察[J].实用中医药杂志,1998,(10).
[56]陈敏,罗绍昌.新加香薷饮加减治疗夏季流感61例[J].湖南中医杂志,1996,(S1).
[57]范秀华,刘波.荆防银翘汤治疗冬季流感120例[J].实用中医内科杂志,2003,17(3)：191.
[58]张韧闻,刘福札,彭小菊,等.益气清解法治疗流行性感冒[J].山东中医杂志,2000,19(8).
[59]刘广杰.流行性感冒的临床诊治[J].中国临床医生杂志,2007,35(2)：13-14.
[60]刘立煜.藿香正气水解痉、镇痛和抗茵作用实验观察[J].中草药,1984,12(15)：15.
[61]周雪仙.藿香正气丸(水)对肠平滑肌的作用[J].中成药研究.1984,(5)：18.
[62]谢肄聪.藿香正气软胶囊对肠屏障功能保护作用的机理研究[J].中国中药杂志,2004,29(5)：456-458.
[63]陆茵.加味藿香正气软胶囊调节胃肠运动功能[J].中药新药与临床药理,2003,14(6)：381-383.
[64]孙政.藿香正气水工艺改进[J].中成药,1990,12(1)：2.
[65]黄德彬.藿香正气口服液对吗啡依赖大鼠戒断症状的影响[J].中成药,2003,25(6)：476-479.
[66]田文艺.藿香正气胶囊和藿香正气水药理作用的比较[J].中成药,1990,12(4)：31.
[67]余传星.藿香正气水阻断肥大细胞脱颗粒的实验研究[J].中医药研究,1994,(4)：60-61.